301 to 310 of 4,130 Results
Adobe PDF - 138.8 KB -
MD5: b8c708b21a69dc184c24b1eea1cbd2ff
|
Tabular Data - 74.3 KB - 91 Variables, 168 Observations - UNF:6:UoitWR6Xi6SSyQc4KewNAQ==
|
Tabular Data - 84.1 MB - 3427 Variables, 7182 Observations - UNF:6:wgYXFp8cGvaLcYIUFzERNg==
|
Tabular Data - 162.3 KB - 2 Variables, 15105 Observations - UNF:6:TgI9Jtz5xCsUFv8KLXqJNA==
|
Unknown - 17.3 KB -
MD5: aac29c28ce0cb14ac8c8189a2f83260e
|
Plain Text - 10.4 KB -
MD5: aa96a3f0128d9d947234da3ebf08bcb0
Informações conjunto de dados |
Unknown - 862.7 KB -
MD5: 242373759817543e68cbbbea3eb2d203
|
Unknown - 9.6 KB -
MD5: 4124e905562951726885a7ab9346ebb2
|
Sep 17, 2024 -
Supplementary Material of the Article "Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis"
Adobe PDF - 19.8 KB -
MD5: 6469ca75ce72e9a41841b17faa5ea601
|
Sep 17, 2024 -
Supplementary Material of the Article "Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis"
Adobe PDF - 155.0 KB -
MD5: 9b33a303e4b814d75cd916cd9e72af7f
Supplementary Material of the Article "Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis" |